The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 04, 2015
Filed:
Nov. 12, 2013
Riccardo Giovannini, Verona, IT;
Cornelia Dorner-ciossek, Warthausen, DE;
Christian Eickmeier, Mittelbiberach, DE;
Dennis Fiegen, Biberach an der Riss, DE;
Thomas Fox, Biberach, DE;
Klaus Fuchs, White Plains, NY (US);
Niklas Heine, Biberach an der Riss, DE;
Holger Rosenbrock, Mittelbiberach, DE;
Gerhard Schaenzle, Biberach an der Riss, DE;
Riccardo Giovannini, Verona, IT;
Cornelia Dorner-Ciossek, Warthausen, DE;
Christian Eickmeier, Mittelbiberach, DE;
Dennis Fiegen, Biberach an der Riss, DE;
Thomas Fox, Biberach, DE;
Klaus Fuchs, White Plains, NY (US);
Niklas Heine, Biberach an der Riss, DE;
Holger Rosenbrock, Mittelbiberach, DE;
Gerhard Schaenzle, Biberach an der Riss, DE;
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Abstract
The invention relates to novel 1,6-disubstituted pyrazolopyrimidinones, wherein i.) the nitrogen atom of the pyrazolo-group that is next to the pyrimidino-group is attached to a non-aromatic, organic heterocycle having at least one ring hetero atom selected from O, N and S and ii.) to the C-atom between the two nitrogen atoms of the pyrimidinone-ring a second substituent is bound via an optionally substituted methylene-bridge. According to one aspect of the invention the new compounds are for the manufacture of medicaments, in particular medicaments for the treatment of conditions concerning deficits in perception, concentration, learning or memory. The new compounds are also for the manufacture of medicaments for the treatment of Alzheimer's disease.